Browsing: biopharma nl

Targeted therapies are bringing new treatment options for a wide range of cancers, but drug resistance still looms for these…

The biotech industry is in the midst of an artificial intelligence (AI) investment surge, with companies pouring billions into the…

The operational structure of the FDA around centers, each governing a particular regulatory or scientific area, dates back more than…

We continue to see enormous technological and scientific progress in the area of drug discovery, with the promise of AI…

With few treatments available for sickle cell disease, encouraging early clinical data for a Fulcrum Therapeutics drug made it one…

Servier is expanding its scope in neurology to include neuromuscular disorders by acquiring a clinical-stage Edgewise Therapeutics drug that offers…

AbbVie’s strategy of growing in oncology by focusing on a particular type of targeted therapy is paying off with another…

Apogee Therapeutics’ lead drug candidate has new mid-stage data indicating it could be competitive with currently available biologic medicines for…

A Daiichi Sankyo and AstraZeneca drug is now approved as a first-line treatment for a particularly difficult-to-treat type of breast…

Next-generation obesity drugs are testing combination approaches intended to lead to greater weight reduction and one of them, an experimental…